AEI · Alset Inc.
$1.41
+0.01 (+0.71%)
At close · Sep 4
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“These conditions initially raised substantial doubt about the Company’s ability to continue as a going concern within one year after the date the consolidated financial statements are issued. ... Based on these factors and management’s plans, management believes that the substantial doubt previously identified has been alleviated.”View the 10-Q filed Aug 14, 2026
Market Cap
$54.84M
Shares
38.90M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$4.47M
+893.5%
FY2025
Net Income
-$47.41M
-1095.6%
FY2025
Gross Margin
27.94%
-1823.9pp
FY2025
Operating Margin
-338.87%
+576pp
FY2025
Diluted EPS
-$2.22
-416.3%
FY2025
Operating Cash Flow
-$5.93M
-215%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| $4.27M | $4.47M | $450K | $22.09M | $4.48M | $19.8M | $16.24M | $24.26M | |
| — | — | — | — | — | — | $16.32K | $52.15K | |
| $3.03M | $3.22M | $12.78M | $14.58M | $3.73M | $11.3M | $12.09M | $19.97M | |
| $1.43M | $1.25M | $8.33M | $7.51M | $748.45K | $8.5M | $4.15M | $4.29M | |
| — | 27.94% | 1851.84% | 34.01% | 16.7% | 42.92% | 25.57% | 17.68% | |
| $13.43M | $15.01M | $10.84M | $9.53M | $7.84M | $23.49M | $6.34M | $5.86M | |
| — | $1.07M | $1.07M | $1.05M | $882.81K | $120.51K | $0 | — | |
| $0 | $0 | $0 | $0 | — | — | $0 | $5.23M | |
| $21.8M | — | — | — | — | $34.79M | $18.42M | $31.2M | |
| $17.18M | $19.62M | $25.23M | $24.96M | $11.57M | $34.79M | — | — | |
| -$12.91M | -$15.15M | -$4.12M | -$2.87M | -$7.09M | -$14.99M | -$2.18M | -$6.94M | |
| — | -338.87% | -914.91% | -13.01% | -158.23% | -75.73% | -13.45% | -28.62% | |
| — | -$14.08M | -$3.04M | -$1.82M | -$6.21M | -$14.87M | -$2.18M | — | |
| -$15.12K | $54.55K | $112.08K | $3979 | $1853 | $317.28K | $147.64K | $372.9K | |
| -$28.78M | -$33.77M | $102.05K | -$58.31M | -$39.12M | -$103.49M | -$2.49M | -$17.53K | |
| -$1.03M | -$2.13M | -$3.23M | -$24.48M | -$685.53K | -$52K | -$227.64K | $0 | |
| — | — | — | — | — | — | -$1.75M | $320.03K | |
| -$41.69M | -$48.92M | -$4.02M | -$61.19M | -$46.21M | -$118.48M | -$4.67M | -$6.96M | |
| — | $432.09K | $150.79K | $92.35K | — | $534.01K | $8543 | $431.39K | |
| -$39.48M | -$47.41M | -$3.97M | -$58.95M | -$40.49M | -$119.02M | -$5.1M | -$8.05M | |
| — | -1060.53% | -881.31% | -266.86% | -903.73% | -601.13% | -31.41% | -33.2% | |
| -$1.45M | -$1.94M | -$199.93K | -$2.33M | -$5.72M | -$15.69M | — | — | |
| -$39M | — | — | — | -$40.49M | -$103.32M | -$3.15M | -$5.23M | |
| -$46.9M | -$47.65M | -$8.65M | -$61.58M | -$45.66M | -$106.12M | -$2.55M | -$5.26M | |
| USD/shares | -$0.99 | -$2.22 | -$0.43 | -$6.52 | -$6.22 | -$73.85 | — | — |
| USD/shares | -$0.99 | -$2.22 | -$0.43 | -$6.52 | -$6.22 | — | — | — |
| shares | — | 21.36M | 9.24M | 9.04M | 6.51M | 1.4M | 417.62K | 500.05K |
| shares | — | 21.36M | 9.24M | 9.04M | 6.51M | 1.4M | 417.62K | 500.05K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 81 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
6.46×
Peer median 2.85×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 8 similar-size Real Estate - Development companies (of 16 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Real Estate Segment | $2,829,270 | $19,608,184 | $20,963,661 | $3,088,628 | $14,213,379 | $13,643,689 |
| Other | $1,641,433 | $1,507,715 | $1,083,971 | $568,248 | $42,377 | — |
| Digital Transformation Technology | $172 | — | $28,117 | $69,915 | — | — |
| Biohealth Business | — | — | $12,758 | $753,651 | $5,543,066 | $2,594,511 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Rental | $2,829,270 | $2,891,807 | $2,776,911 | $1,810,011 | $327,296 | — |
| Other | $1,641,605 | $1,507,715 | $1,083,971 | $568,248 | $42,377 | — |
| Biohealth | — | — | $12,758 | $753,651 | $5,543,066 | $2,594,511 |
| Digital Transformation Technology | — | — | — | $69,915 | — | — |
| Digital Transformation Technology Related Party | — | — | $28,117 | $69,915 | — | — |
| Property | — | $16,716,377 | $18,186,750 | $1,278,617 | $13,886,083 | — |
| Real Estate Property | — | — | — | — | — | $13,643,689 |
| Revenue From Other Busines | — | — | — | $568,248 | $42,377 | — |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Digital Transformation Technology | -$591,070 | -$616,403 | -$449,707 | -$367,675 | -$183,429 | -$54,673 |
| Biohealth Business | -$1,366,561 | -$1,079,465 | -$911,454 | -$619,927 | $1,704,847 | $743,677 |
| Real Estate Segment | -$3,218,964 | $5,780,648 | $5,736,493 | -$1,407,246 | $2,003,592 | $1,203,058 |
| Other | -$9,973,988 | -$8,201,857 | -$7,247,986 | -$4,694,526 | -$18,519,132 | -$4,076,800 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Real Estate Segment | -113.8% | 29.5% | 27.4% | -45.6% | 14.1% | 8.8% |
| Other | -607.6% | -544% | -668.7% | -826.1% | -43700.9% | — |
| Digital Transformation Technology | -343645.3% | — | -1599.4% | -525.9% | — | — |
| Biohealth Business | — | — | -7144.2% | -82.3% | 30.8% | 28.7% |
Key facts
CIK
1750106
CUSIP
02115D208
13F (30d)
17 filings
17 filers
Visit website
Investor relations